Effects of Goserelin and Anastrozole on Hormone Levels in Breast Cancer Treatment
Author Information
Author(s): Mitwally M F, Casper R F, Diamond M P
Primary Institution: Wayne State University
Hypothesis
The study investigates how goserelin and anastrozole affect gonadotropin and androgen levels in premenopausal women with advanced breast cancer.
Conclusion
The introduction of goserelin and anastrozole led to a significant rise in FSH levels after an initial drop with goserelin and tamoxifen treatment.
Supporting Evidence
- Goserelin and tamoxifen led to a 90% fall in FSH levels.
- After switching to goserelin and anastrozole, FSH levels rose significantly.
- Testosterone and androstenedione levels fell with anastrozole treatment.
Takeaway
Doctors studied how two treatments for breast cancer affect hormone levels in women, finding that one treatment caused a big change in a hormone called FSH.
Methodology
The study analyzed serum gonadotropin and androgen levels in patients treated with goserelin and either tamoxifen or anastrozole.
Limitations
The evidence primarily comes from animal studies, which may not fully translate to human responses.
Participant Demographics
Premenopausal women with advanced breast cancer.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website